Moderna : Une franchise vaccins qui se structure de plus en plus
>Une accélération de l’ensemble des programmes contre les virus latents - Le Journée Vaccins de Moderna a permis de remettre en exergue un portefeuille cohérent et ambitieux de l’ARNm contre les maladies infectieuses (28 candidats vaccins en développement). Mis à part son vaccin COVID-19, nous retenons notamment les avancées de son vaccin contre le CytoMegaloVirus congénital (phase 3, entièrement recruté ; n=7300) et dont la probabilité de succès s’améliore avec le te...Moderna is creating a new generation of medicines based on messenger RNA to improve the lives of patients. The company uses its platform to identify and develop new mRNA medicines. When the company identifies a combination of platform technologies or programs across mRNA technologies, delivery technologies, and manufacturing processes that can enable shared product features across multiple potential mRNA medicines, it groups those programs as a modality. The company has created six modalities including prohylactic vaccines; cancer vaccines; intratumoral immuno-oncology; localized regenerative therapeuctics; systemic secreted therapeutics; and systemic intracellular therapeutics.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.